Skip to main content

Table 1 Baseline characteristics

From: Health-Related Quality of Life after Ischemic Stroke: The Impact of Pharmaceutical Interventions on Drug Therapy (Pharmaceutical Care Concept)

Characteristics Intervention Group
n = 90
Control
Group
n = 165
Age, mean ± SD (years) 68.2 (± 9.7) 68.1 (± 10.8)
   Min 45 23
   Max 85 85
Sex, n (%)   
   female 35 (38.9%) 58 (35.2%)
   male 55 (61.1%) 107 (64.8%)
subtype of cerebral ischemia, n (%)   
   TIA 28 (31.1%) 49 (29.7%)
   Ischemic stroke 62 (68.9%) 116 (70.3%)
Barthel Index, mean ± SD 92,8 (± 7,5) 89,4 (± 14,3)
cardiovascular risk factors   
   hypertension 33 (36.7%) 61 (37.0%)
   hyperlipidemia 6 (6.7%) 5 (3.0%)
   diabetes mellitus 1 (1.1%) 2 (1.2%)
   hypertension+hyperlipidemia 31 (34.4%) 46 (27.9%)
   hypertension+diabetes mellitus 4 (4.4%) 20 (12.1%)
   diabetes mellitus+hyperlipidemia -- 2 (1.2%)
   hypertension+diabetes   
   mellitus+hyperlipidemia 7 (7.8%) 15 (9.1%)
   None 8 (8.9%) 14 (8.5%)
  1. SD = Standard deviation